Methods for Tumor Targeting with Salmonella typhimurium A1-R

Area of Science:

• Oncology
• Microbiology
• Preclinical Research

Background:

• Salmonella typhimurium A1-R demonstrates significant preclinical potential as a broad-spectrum anti-cancer therapeutic.
• Effective preclinical evaluation requires robust and clinically relevant models.

Purpose of the Study:

• To describe materials and methods for preclinical studies of S. typhimurium A1-R.
• To establish and utilize clinically relevant mouse models for efficacy and safety assessments.
• To provide methodologies translatable for future clinical studies.

Main Methods:

• Establishment of orthotopic metastatic mouse models for major cancer types.
• In vitro and in vivo imaging of GFP-labeled S. typhimurium A1-R and fluorescently labeled cancer cells.
• Evaluation of S. typhimurium A1-R in models of metastasis to liver, lung, bone, and brain.
• Assessment of various administration routes, toxicity, and combination therapies with chemotherapy.
• Testing in patient-derived orthotopic xenograft (PDOX) models.

Main Results:

• Detailed methodologies for preclinical evaluation of S. typhimurium A1-R are presented.
• The described models allow for visualization and quantification of bacterial targeting and anti-cancer effects.
• The study outlines approaches for assessing safety and efficacy across various cancer types and metastatic sites.

Conclusions:

• The methodologies described provide a framework for the preclinical assessment of S. typhimurium A1-R.
• These methods are designed to be translatable to clinical settings, facilitating the advancement of this therapeutic.
• The study supports the continued development of S. typhimurium A1-R as a novel anti-cancer agent.